Addus HomeCare Corporation (ADUS) - Stock Analysis

Last updated: Jan 18, 2026

HealthcareClosed

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.

Loading chart data...

Idea window: 10/20/2025 – 10/27/2025Sector: Healthcare

AI Analyst Overview

Last Price
$107.51
Market Cap
$1987.04
1D Return
-2.09%
YTD Return
+0.11%

Loading chart data...

Valuation Metrics

P/E
23.1
P/B
1.9
P/S
1.5
EV/EBITDA
15.1
Div Yield
—

Fundamental Analysis

8.0

Key Financial Insights: • Strong free cashflow • Large intangible base • High SG&A burden ADUS generates strong, consistent free cash flow and improving leverage but only moderate margins and adequate liquidity while facing material risk from a very large intangible asset base and cash-flow volatility.

StrongFCF
IntangibleRisk

Price Behavior

6.0

Key Price Behavior Insights: • Failed resistance • Maintained support • Moderate momentum Support Level: $107–$109 Resistance Level: $115–$117 Over the last month ADUS has trended modestly lower from a mid‑December peak near $115 to about $107.5 by mid‑January, encountering resistance at $115–$117 while holding support around $107–$109, indicating short-term bearish pressure but limited downside so far.

caution
stable

Sentiment & News

7.0

Key News Insights: • Zacks upgrade • AI & home-care • Peer comparisons December headlines show rising optimism for Addus (ADUS) driven by a Zacks upgrade, AI and home-care tailwinds, and favorable peer comparisons highlighting improving earnings and competitive position.

Bullish
Healthcare
AI

AI Summary

7.0
Positive

ADUS's investment pivot hinges on whether management can convert acquisition-driven revenue and state reimbursement tailwinds into repeatable free-cash-flow and mid‑teens EBITDA margins without overleveraging or triggering goodwill impairments; investors should therefore monitor quarterly FCF stability, net leverage staying <1x, and concrete EMR/integration milestones as the primary go/no‑go signals. The biggest actionable risk is execution — failures on integration, EMR consolidation, or reimbursement permanence would rapidly reverse the upside and amplify impairment and cash‑volatility exposure.

CashConversion
IntegrationRisk
Reimbursement
AI summary updated today

Description

Addus HomeCare provides in-home personal care, hospice, and home health services to elderly, chronically ill, disabled people and those at risk of hospitalization in the United States. Its Personal Care unit supplies non-medical assistance with daily living activities, the Hospice unit delivers palliative and family support services, and the Home Health unit offers skilled nursing and rehabilitative therapies. The company contracts with government programs, managed care organizations, commercial insurers and private clients, and as of December 31, 2021 operated 206 offices in 22 states; it was founded in 1979 and is based in Frisco, Texas.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Oct 20Oct 27ADUSAddus HomeCare Corporation
Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.
Closed+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.